Silver-Russell syndrome (SRS, OMIM, 180860) is a rare genetic disorder with a wide spectrum of symptoms. The most common features are intrauterine growth retardation (IUGR), poor postnatal development, macrocephaly, triangular face, prominent forehead, body asymmetry, and feeding problems. The diagnosis of SRS is based on a combination of clinical features. Up to 60% of SRS patients have chromosome 7 or 11 abnormalities, and <1% show abnormalities in IGF2 signaling pathway genes (IGF2, HMGA2, PLAG1 and CDKN1C). The underlying genetic cause remains unknown in about 40% of cases (idiopathic SRS). We report a novel IGF2 variant c.[-6-2A>G] (NM_000612) in a child with severe IUGR and clinical features of SRS and confirm the utility of targeted exome sequencing in patients with negative results to common genetic analyses. In addition, we report that long-term growth hormone treatment improves height SDS in this patient.

Case report. Long term response to growth hormone in a child with Silver-Russell syndrome-like phenotype due to a novel paternally inherited IGF2 variant / Ventresca, Silvia; Romana Lepri, Francesca; Criscuolo, Sabrina; Bottaro, Giorgia; Novelli, Antonio; Loche, Sandro; Cappa, Marco. - In: FRONTIERS IN ENDOCRINOLOGY. - ISSN 1664-2392. - 15:(2024), pp. 1-7. [10.3389/fendo.2024.1364234]

Case report. Long term response to growth hormone in a child with Silver-Russell syndrome-like phenotype due to a novel paternally inherited IGF2 variant

Silvia Ventresca
Primo
Writing – Original Draft Preparation
;
Antonio Novelli
Data Curation
;
2024

Abstract

Silver-Russell syndrome (SRS, OMIM, 180860) is a rare genetic disorder with a wide spectrum of symptoms. The most common features are intrauterine growth retardation (IUGR), poor postnatal development, macrocephaly, triangular face, prominent forehead, body asymmetry, and feeding problems. The diagnosis of SRS is based on a combination of clinical features. Up to 60% of SRS patients have chromosome 7 or 11 abnormalities, and <1% show abnormalities in IGF2 signaling pathway genes (IGF2, HMGA2, PLAG1 and CDKN1C). The underlying genetic cause remains unknown in about 40% of cases (idiopathic SRS). We report a novel IGF2 variant c.[-6-2A>G] (NM_000612) in a child with severe IUGR and clinical features of SRS and confirm the utility of targeted exome sequencing in patients with negative results to common genetic analyses. In addition, we report that long-term growth hormone treatment improves height SDS in this patient.
2024
GH therapy; IGF2 variant; Silver-Russel syndrome; children; growth retardation
01 Pubblicazione su rivista::01a Articolo in rivista
Case report. Long term response to growth hormone in a child with Silver-Russell syndrome-like phenotype due to a novel paternally inherited IGF2 variant / Ventresca, Silvia; Romana Lepri, Francesca; Criscuolo, Sabrina; Bottaro, Giorgia; Novelli, Antonio; Loche, Sandro; Cappa, Marco. - In: FRONTIERS IN ENDOCRINOLOGY. - ISSN 1664-2392. - 15:(2024), pp. 1-7. [10.3389/fendo.2024.1364234]
File allegati a questo prodotto
File Dimensione Formato  
Ventresca_Case-report_2024.pdf

accesso aperto

Note: Articolo su rivista
Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 1.37 MB
Formato Adobe PDF
1.37 MB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1722486
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact